ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Portable Butterfly iQ+ ultrasound system for University Hospital Bonn and Faculty of Medicine Students

As the first healthcare institution in Europe to do so, UKB and the Faculty of Medicine will provide medical students with personal, state-of-the-art, whole-body Butterfly iQ+ devices and implement Butterfly's Blueprint platform throughout UKB to further improve medical education, research and patient care.

The collaboration will include clinical integration at UKB and also evaluate impacts on care processes.

For the first time in Europe, the University Hospital Bonn (UKB) and the Medical Faculty Bonn are using the advanced ultrasound system Butterfly Blueprint™ from the U.S.-headquartered digital health company, Butterfly Network, Inc., to teach medical and midwifery students at the UKB. The innovative, semiconductor chip-based Butterfly iQ+ can enable more informed diagnosis and treatment directly at the patient's bedside and support complex ultrasound training integrated into studies throughout the UKB campus.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230222005861/en/

Prof. Wolfgang Holzgreve, two students, Prof. Bernd Weber and PD Dr. Valentin Schäfer examining a patient with the Butterfly iQ+ system. Photo credit: University Hospital Bonn (UKB)/A. Winkler

Prof. Wolfgang Holzgreve, two students, Prof. Bernd Weber and PD Dr. Valentin Schäfer examining a patient with the Butterfly iQ+ system. Photo credit: University Hospital Bonn (UKB)/A. Winkler

Ultrasound diagnostics is one of the most important imaging procedures in medicine. It can be used to inform clinical assessment by nearly every medical specialty, and carries no side effects for patients. "However, ultrasound images are often not easy to interpret - which is why the UKB and the Medical Faculty promote early training and practical experience for medical and midwifery students," says PD Dr. Valentin Schäfer, head of rheumatology and the internal sonography center at the UKB. As the first healthcare institution in Europe to do so, UKB and the Faculty of Medicine will provide medical students with personal, state-of-the-art, whole-body Butterfly iQ+ devices and implement Butterfly's Blueprint platform throughout UKB to further improve medical education, research and patient care.

The medical school first engaged with the U.S. provider of this mobile ultrasound system in early 2020, becoming one of the largest contingents in Europe at the time, with more than 30 devices. The use of the portable devices has since proven successful: Numerous studies have been published from Bonn, which above all demonstrate the benefits in medical education. Butterfly is the only supplier to date to provide a single-probe, whole-body transducer with unique Ultrasound-on-Chip™ technology that converts a compatible smartphone or tablet into an imaging instrument, enabling the practical application of ultrasound information in the clinical workflows of medical staff. For that reason, the collaboration will now be expanded to include clinical integration at UKB and also evaluate impacts on care processes. The device fits in a pocket and is powered by a combination of cloud-connected software and hardware technology in a privacy-compliant manner that can be accessed via a mobile app.

"We are pleased that the Butterfly portable devices, with their combination of whole-body ultrasound probe, software, cloud connectivity, and integration into clinical and administrative systems and workflows, will be used at our UKB, further optimizing ultrasound diagnostics in teaching and patient care," said Prof. Wolfgang Holzgreve, Medical Director and CEO of UKB.

"Point-of-care ultrasound, i.e. ultrasound diagnostics close to the patient, will certainly be essential for our students in the future," says Prof. Bernd Weber, Dean of the Medical Faculty at the University of Bonn. "We accompany the personal equipment of our students with personal Butterfly devices with a specific curriculum, initially in the practical year, which incorporates ultrasound knowledge across disciplines and even more comprehensively." At UKB and the Medical School, Butterfly Network's portable imaging devices will be introduced as early as next summer semester and will be available to students in the practical year from then on.

"We are proud to collaborate with UKB and the Faculty of Medicine to further embed our technology into its healthcare system with enhanced access to training and education, affordable equipment, and practical encounter-based workflows that are uniquely offered with the Butterfly Blueprint system. Through this collaboration, students at this premier European medical institution will access state-of-the-art healthcare technology and educational assets to ultimately become proficient in using ultrasound information directly at the bedside," said Niki Montgomery, Sr. Vice President, Commercial Development at Butterfly Network, Inc.

PD Dr. Schäfer and Dr. Florian Recker, specialist in obstetrics and prenatal medicine at the UKB, are in charge of the project at the UKB and will provide scientific support. The start of the rollout begins with the new curriculum, which will be known as the BI-POCUS project (Bonn Internship Point-of-Care-Ultrasound) in the students' practical year.

About the University Hospital Bonn: The UKB cares for about 500,000 patients per year, employs 8,800 people and has a balance sheet total of 1.5 billion euros. In addition to the more than 3,300 medical and dental students, a further 580 people are trained each year in numerous healthcare professions. The UKB is ranked number 1 among university hospitals (UK) in NRW in the science ranking as well as in the Focus clinic list and has the third highest case mix index (case severity index) in Germany.

About Butterfly Network: Founded in 2011 by Jonathan Rothberg, Ph.D., and listed on the New York Stock Exchange through a business combination with Longview Acquisition Corp, Butterfly created the world's first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. Butterfly's mission is to democratize medical imaging and contribute to the aspiration of global health equity, making high-quality ultrasound affordable, easy-to-use, globally accessible and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip™ technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. Butterfly iQ+ can be purchased today by trained healthcare practitioners in areas including, but not limited to, Africa, Asia, Australia, Europe, North America and South America; to learn more about available countries, visit: butterflynetwork.com/choose-your-country.

Contacts

Press contact:

Viola Röser

Press Officer at the University Hospital Bonn (UKB)

Communications and Media Office at Bonn University Hospital

Phone: +49 228 287- 10469

E-mail: viola.roeser@ukbonn.de



Liz Learned

Butterfly Network

Media@butterflynetwork.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.